Niedzwiecki D - Search Results

1

Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma.

Schneider A, Kemeny N, Chapman D, Niedzwiecki D, Oderman P. Schneider A, et al. Among authors: niedzwiecki d. Cancer. 1989 Dec 1;64(11):2203-6. doi: 10.1002/1097-0142(19891201)64:11<2203::aid-cncr2820641103>3.0.co;2-o. Cancer. 1989. PMID: 2529960

2

A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, Botet J, Oderman P, Murray P. Kemeny N, et al. Among authors: niedzwiecki d. Cancer. 1992 Jan 15;69(2):327-34. doi: 10.1002/1097-0142(19920115)69:2<327::aid-cncr2820690209>3.0.co;2-u. Cancer. 1992. PMID: 1303612 Clinical Trial.

3

Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing.

Sutanto-Ward E, Sigurdson ER, Tremiterra S, Lincer R, Chapman D, Niedzwiecki D. Sutanto-Ward E, et al. Among authors: niedzwiecki d. Surg Oncol. 1992 Feb;1(1):87-95. doi: 10.1016/0960-7404(92)90061-o. Surg Oncol. 1992. PMID: 1341240

4

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.

Atiq OT, Kemeny N, Niedzwiecki D, Botet J. Atiq OT, et al. Among authors: niedzwiecki d. Cancer. 1992 Feb 15;69(4):920-4. doi: 10.1002/1097-0142(19920215)69:4<920::aid-cncr2820690414>3.0.co;2-y. Cancer. 1992. PMID: 1370918

5

Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines.

Li WW, Lin JT, Schweitzer BI, Tong WP, Niedzwiecki D, Bertino JR. Li WW, et al. Among authors: niedzwiecki d. Cancer Res. 1992 Jul 15;52(14):3908-13. Cancer Res. 1992. PMID: 1377601

6

Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma.

Niedt GW, Myskowski PL, Urmacher C, Niedzwiecki D, Chapman D, Krown SE, Safai B. Niedt GW, et al. Among authors: niedzwiecki d. Hum Pathol. 1992 Dec;23(12):1419-26. doi: 10.1016/0046-8177(92)90063-9. Hum Pathol. 1992. PMID: 1468779

7

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M. Kelsen D, et al. Among authors: niedzwiecki d. J Clin Oncol. 1992 Apr;10(4):541-8. doi: 10.1200/JCO.1992.10.4.541. J Clin Oncol. 1992. PMID: 1548519 Clinical Trial.

8

Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.

Kemeny N, Conti JA, Seiter K, Niedzwiecki D, Botet J, Martin D, Costa P, Wiseberg J, McCulloch W. Kemeny N, et al. Among authors: niedzwiecki d. J Clin Oncol. 1992 May;10(5):747-52. doi: 10.1200/JCO.1992.10.5.747. J Clin Oncol. 1992. PMID: 1569447

9

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.

Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D, Bains M, Burt M, Heelan R, Hilaris B. Kelsen DP, et al. Among authors: niedzwiecki d. J Clin Oncol. 1990 Aug;8(8):1352-61. doi: 10.1200/JCO.1990.8.8.1352. J Clin Oncol. 1990. PMID: 1696309 Clinical Trial.

10

A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA).

Kemeny N, Seiter K, Martin D, Urmacher C, Niedzwiecki D, Kurtz RC, Costa P, Murray M. Kemeny N, et al. Among authors: niedzwiecki d. Ann Intern Med. 1991 Dec 15;115(12):946-51. doi: 10.7326/0003-4819-115-12-946. Ann Intern Med. 1991. PMID: 1824554 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters